Have you experienced any symptoms of anxiety or depression as a result of the COVID-19 pandemic?
29%Yes
29%No
4%Don't know
The COVID-19 pandemic has left no aspect of the global healthcare industry untouched. Healthcare organizations are facing unprecedented challenges as developers and providers of essential products and services, as business entities, as employers, and as influential members of their communities.
The situation is evolving at a breakneck pace. COVID-19 outbreaks are continuing to strain resources, virus mutations are raising new questions, and governments and healthcare organizations worldwide are struggling with the enormous, complicated task of rolling out vaccination programs.
In this environment, healthcare leaders must have reliable information they can turn to as they make strategic decisions that affect their patients, finances, employees and communities. Since the beginning of the pandemic, PwC's Global Health Industries experts have been helping to inform the industry response.
Below are resources that provide valuable insights for leaders across the healthcare ecosystem as they navigate these challenging times.
Explore data from PwC's 2021 global health consumer survey
In April 2021, PwC published Global Top Health Industry Issues 2021, which focuses on four top issues that were given a shot of momentum by the response to the COVID-19 pandemic, and that will continue to grow in strength. Our research was backed by new results from a PwC survey of 10,000 consumers across 10 territories, conducted in January 2021. See below for highlights by territory or global.
Explore data from PwC's 2021 global health consumer survey
Filter the data by region
Would you participate in a remotely-conducted clinical trial to help develop healthcare treatments or vaccines?
29%Willing
23%Unwilling
11%Not sure
Of the virtual settings you have used to receive healthcare treatment, would you be willing to use these again once the pandemic risk has decreased and a COVID-19 vaccine has mass adoption?
29%Phone
29%Text
29%Email
29%Mobile app
For those hesitant to receive the vaccine, what would encourage you to get the COVID-19 vaccine sooner?
23%If my family and friends got the vaccine
29%If there was more evidence/information available on it
29%It was a requirement for something I wanted to do (e.g. travel, go to a concert etc)
29%There was no cost associated
3%Other
10%I don't know
Attitudes toward receiving the COVID-19 vaccine
29%Enthusiasts (straightaway)
29%Hesitants (would get it but not as soon as it was available to them)
8%Never
Methods used to receive healthcare treatment (Before and/or during the pandemic)
14%Video virtual care visit (e.g., using technology to virtually see and talk to a medical professional)17%Video virtual care visit (e.g., using technology to virtually see and talk to a medical professional)
24%Phone call to a medical professional29%Phone call to a medical professional
11%Texting with a medical professional12%Texting with a medical professional
12%Emailing with a medical professional13%Emailing with a medical professional
14%Mobile app to communicate with a medical professional15%Mobile app to communicate with a medical professional
29%None of the above29%None of the above
Of those who would never receive the COVID-19 vaccine, why not?
24%I do not believe in vaccinations
9%Due to the potential cost of the vaccine
28%I do not trust the vaccine will work
28%I think it has been developed too fast
27%Due to potential health concerns in taking the vaccine
5%Due to a lack of access to receive the vaccine
9%Other
3%I don't know
Willingness of those who have already used video virtual care to use it again once the pandemic risk has decreased
26%Respondents answering "yes"
| Jurisdictions | Global | Australia | Canada | China | Germany | India | Japan | Singapore | South Africa | UK | US |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Have you experienced any symptoms of anxiety or depression as a result of the COVID-19 pandemic? | |||||||||||
| Yes | 36% | 38% | 43% | 33% | 26% | 55% | 8% | 30% | 50% | 41% | 40% |
| No | 60% | 58% | 54% | 65% | 68% | 42% | 85% | 67% | 47% | 55% | 55% |
| Don't know | 4% | 4% | 3% | 2% | 5% | 2% | 7% | 4% | 3% | 4% | 5% |
| Would you participate in a remotely-conducted clinical trial to help develop healthcare treatments or vaccines? | |||||||||||
| Willing | 66% | 63% | 63% | 84% | 60% | 87% | 35% | 66% | 71% | 71% | 60% |
| Unwilling | 23% | 22% | 25% | 12% | 27% | 9% | 47% | 22% | 21% | 17% | 25% |
| Not sure | 11% | 16% | 12% | 4% | 13% | 4% | 18% | 12% | 8% | 12% | 15% |
| Of the virtual settings you have used to receive healthcare treatment, would you be willing to use these again once the pandemic risk has decreased and a COVID-19 vaccine has mass adoption? | |||||||||||
| Phone | 83% | 81% | 82% | 86% | 79% | 92% | 71% | 77% | 90% | 76% | 80% |
| Text | 78% | 75% | 71% | 75% | 78% | 84% | 80% | 75% | 88% | 63% | 70% |
| 80% | 73% | 83% | 76% | 77% | 87% | 78% | 72% | 88% | 71% | 82% | |
| Mobile app | 81% | 71% | 72% | 87% | 63% | 86% | 70% | 75% | 84% | 75% | 85% |
| For those hesitant to receive the vaccine, what would encourage you to get the COVID-19 vaccine sooner? | |||||||||||
| If my family and friends got the vaccine | 23% | 18% | 23% | 45% | 19% | 36% | 18% | 26% | 15% | 21% | 18% |
| If there was more evidence/information available on it | 57% | 54% | 52% | 53% | 51% | 59% | 63% | 64% | 74% | 47% | 50% |
| It was a requirement for something I wanted to do (e.g. travel, go to a concert etc) | 32% | 33% | 36% | 44% | 30% | 39% | 18% | 41% | 27% | 29% | 30% |
| There was no cost associated | 32% | 28% | 29% | 47% | 25% | 29% | 36% | 40% | 28% | 21% | 28% |
| Other | 3% | 3% | 4% | 0% | 4% | 2% | 2% | 2% | 3% | 3% | 4% |
| I don't know | 10% | 13% | 9% | 3% | 13% | 7% | 14% | 5% | 7% | 14% | 17% |
| Attitudes toward receiving the COVID-19 vaccine | |||||||||||
| Enthusiasts (straightaway) | 45% | 42% | 49% | 50% | 43% | 68% | 18% | 28% | 40% | 65% | 47% |
| Hesitants (would get it but not as soon as it was available to them) | 47% | 53% | 43% | 46% | 46% | 29% | 71% | 66% | 43% | 32% | 40% |
| Never | 8% | 6% | 8% | 4% | 11% | 3% | 11% | 6% | 17% | 4% | 13% |
| Methods used to receive healthcare treatment (Before and/or during the pandemic) | |||||||||||
| Video virtual care visit (e.g., using technology to virtually see and talk to a medical professional) | 14%,17% | 14%,15% | 11%,16% | 20%,22% | 7%,9% | 33%,39% | 3%,3% | 13%,15% | 7%,12% | 7%,11% | 22%,29% |
| Phone call to a medical professional | 24%,29% | 22%,35% | 23%,40% | 29%,29% | 28%,24% | 44%,43% | 6%,7% | 14%,16% | 23%,25% | 30%,39% | 23%,27% |
| Texting with a medical professional | 11%,12% | 10%,11% | 6%,7% | 19%,20% | 5%,5% | 30%,32% | 2%,2% | 10%,11% | 12%,14% | 5%,7% | 11%,11% |
| Emailing with a medical professional | 12%,13% | 11%,13% | 9%,12% | 16%,17% | 9%,8% | 26%,28% | 2%,3% | 11%,12% | 14%,15% | 8%,10% | 15%,16% |
| Mobile app to communicate with a medical professional | 14%,15% | 11%,13% | 7%,8% | 36%,35% | 5%,5% | 36%,35% | 3%,3% | 15%,14% | 11%,12% | 7%,7% | 13%,13% |
| None of the above | 58%,52% | 60%,46% | 63%,43% | 40%,40% | 60%,62% | 28%,23% | 90%,89% | 68%,63% | 64%,61% | 56%,47% | 52%,45% |
| Of those who would never receive the COVID-19 vaccine, why not? | |||||||||||
| I do not believe in vaccinations | 24% | 19% | 20% | 14% | 17% | 23% | 25% | 38% | 30% | 19% | 22% |
| Due to the potential cost of the vaccine | 9% | 2% | 9% | 28% | 4% | 7% | 19% | 7% | 10% | 0% | 6% |
| I do not trust the vaccine will work | 42% | 46% | 41% | 19% | 47% | 33% | 26% | 50% | 46% | 35% | 50% |
| I think it has been developed too fast | 44% | 42% | 45% | 11% | 52% | 20% | 26% | 50% | 49% | 59% | 52% |
| Due to potential health concerns in taking the vaccine | 47% | 53% | 49% | 39% | 56% | 33% | 48% | 45% | 46% | 32% | 45% |
| Due to a lack of access to receive the vaccine | 5% | 4% | 5% | 6% | 3% | 10% | 7% | 5% | 5% | 3% | 2% |
| Other | 9% | 12% | 12% | 0% | 13% | 10% | 2% | 5% | 10% | 11% | 11% |
| I don't know | 3% | 7% | 2% | 3% | 4% | 0% | 7% | 0% | 1% | 5% | 1% |
| Willingness of those who have already used video virtual care to use it again once the pandemic risk has decreased | |||||||||||
| Respondents answering "yes" | 91% | 89% | 84% | 96% | 90% | 97% | 86% | 94% | 83% | 91% | 86% |
Insights
Loading...
How New Zealand’s Whakarongorau Aotearoa is improving equity in healthcare
CEO Andrew Slater describes how the telehealth company has scaled up to meet unprecedented demand while staying true to its mission.
The COVID-19 Vaccination Journey: Five Critical Considerations for Governments
A COVID-19 vaccine may allow communities and economies to heal and recover, but only with sufficient levels of adoption. The road to vaccination is complex. What are the key considerations for governments along this journey? My thoughts are captured below.
COVID-19 vaccines, a catalyst for evolution in the Pharma supply chain?
COVID-19 vaccines, a catalyst for evolution in the Pharma supply chain? The world is abuzz with excitement about the new COVID-19 vaccines and the promise of a better year in 2021. News coverage over the past weeks and months has featured in detail the unprecedented speed with which these new vaccines have been...
Loading...
Loading...
Global M&A trends in health industries: 2025 outlook
Health industries dealmakers gear up for a more favourable M&A environment in 2025.
Podcast: Exploring the future of work with Toby Hall, Group CEO, St. Vincent's Health Australia
Learn how healthcare has upskilled and retrained its people during the pandemic.
Pfizer’s vaccine machine
CEO Albert Bourla discusses how a company founded in the 19th century is taking on the biggest health challenges of the 21st century.
COVID-19 means insurers should pick up the pace on improving experiences
In an industry driven and sustained by trust, the pandemic has brought both challenges and opportunities for customer and employee experience.
COVID-19 places a heightened emphasis on mental health
Companies must focus on the social factors that can influence employee performance.
Accelerating the health economy of tomorrow
The pandemic edits the DNA of the health system
Tech powered healthcare
A strategic approach to implementing technology in health and care
5G In Healthcare
5G networks could transform—and improve—all of the critical components of healthcare, a subject especially meaningful today as the spread of the coronavirus has put unprecedented stress on healthcare systems around the world.
Where next for healthcare?
The forces of change that will shape the post COVID-19 recovery for Australia’s health and aged care sectors.
Where next for healthcare?
COVID-19 provides fresh impetus to build a healthcare system that works better for the NHS, the public and the wider health industry.
Where next for pharmaceutical?
Pharma companies now have an opportunity to take the lead and begin to redefine their role in the wider healthcare ecosystem.
Designing an app to combat the spread of COVID-19 in Germany
In less than 48 hours, a team from PwC, Strategy&, IXDS and SIS Software developed a smartphone app to help combat the spread of COVID-19, in response to a challenge set by the German government.
Loading...
